Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-C Wasmuth

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
European Journal of Medical Research|August 5, 2011
Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B geneP Lutz, J-C Wasmuth, H-D Nischalke, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 14, 2018
Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, GermanyM Stecher, A Chaillon, A M Eis-Hübinger, et al.
HIV Medicine|March 20, 2013
Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patientsA Jansen, E P H Colbers, A J A M van der Ven, et al.
European Journal of Medical Research|April 14, 2011
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetenceM Vogel, O Friedrich, G Lüchters, et al.
Infection|June 1, 2026
Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis?S Dirik, C Boesecke, S Breitschwerdt, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
HIV Medicine|May 12, 2015
Pulmonary hypertension in HIV infection: a prospective echocardiographic studyC Schwarze-Zander, S Pabst, C Hammerstingl, et al.
Journal of Viral Hepatitis|July 22, 2014
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infectionC Boesecke, S van Assen, H-J Stellbrink, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
European Journal of Medical Research|August 5, 2011
Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B geneP Lutz, J-C Wasmuth, H-D Nischalke, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 14, 2018
Pretreatment human immunodeficiency virus type 1 (HIV-1) drug resistance in transmission clusters of the Cologne-Bonn region, GermanyM Stecher, A Chaillon, A M Eis-Hübinger, et al.
HIV Medicine|March 20, 2013
Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patientsA Jansen, E P H Colbers, A J A M van der Ven, et al.
European Journal of Medical Research|April 14, 2011
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetenceM Vogel, O Friedrich, G Lüchters, et al.
Infection|June 1, 2026
Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis?S Dirik, C Boesecke, S Breitschwerdt, et al.
HIV Medicine|January 29, 2019
Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfectionJ J Malin, C Boesecke, C Schwarze-Zander, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
HIV Medicine|May 12, 2015
Pulmonary hypertension in HIV infection: a prospective echocardiographic studyC Schwarze-Zander, S Pabst, C Hammerstingl, et al.
Journal of Viral Hepatitis|July 22, 2014
Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infectionC Boesecke, S van Assen, H-J Stellbrink, et al.
Pageof 5